Xiidra is a prescription eye drop solution designed to treat the signs and symptoms of dry eye disease. Xiidra has been studied in more than 1,000 patients with dry eye in four separate, 12-week clinical studies. Xiidra was proven to reduce symptoms of eye dryness in all four studies and Inferior fluorescein Corneal Staining Score in three of the four studies in some patients at week 12.
eye drop solution, dry eye disease, dryness
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Xiidra? We’re happy to assist you with our Startup Sourcing service.